Clinical trial
Overnight Dexamethasone in Primary Aldosteronism Screening in Patients on Interfering Therapy (the ODEPRASC Study)
NCT06740838 is registered in ClinicalTrials.gov with Medical University of Gdansk as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Overnight Dexamethasone in Primary Aldosteronism Screening in Patients on Interfering Therapy (the ODEPRASC Study)
- Lead sponsor
- Medical University of Gdansk
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- October 22, 2024
- Completion date
- October 31, 2026
- Enrollment
- 240 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hypertension, primary aldosteronism